Relapsed/Refractory Peripheral T-Cell Lymphoma
1 competing product in clinical development for Relapsed/Refractory Peripheral T-Cell Lymphoma.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Valemetostat Tosylate | Daiichi Sankyo | Phase 2 | Active | 39 |